Regarding The Salary Payment Of Indofarma Employees Who Are In Arrears, Deputy Minister Of SOEs: Wait For PKPU First

Deputy Minister of BUMN Kartika Wirjoatmodjo (Photo: dock VOI)

Deputy Minister of State-Owned Enterprises (BUMN) Kartika Wirjoatmodjo said that the payment of salaries for employees of PT Indofarma (Persero) Tbk (INAF) is still waiting for the process of Postponing Debt Payment Obligations (PKPU).

"We are PKPU (Delaying Debt Payment Obligations) first, so that we can take care of the crime related to the fraud," Kartika said quoting Antara.

The man who is familiarly called Tiko revealed that if the PKPU process has been completed, it will then be recalculated on how much employee salary needs have not been paid by the pharmaceutical company.

"And after that (PKPU Process), we will recount how much it needs for employees," said Tiko.

Even so, the Deputy Minister of BUMN also admitted that he did not memorize in detail the nominal salary of PT Indofarma employees who had not been paid.

"I don't remember the employee salary that has not been paid, but we are in the PKPU process (Delayment of Debt Payment Obligations)," said Tiko as he rushed to the car he was traveling in.

Earlier on Monday (20/5), the BPK submitted an Investigative Examination Result Report (LHP) related to Indofarma Financial Management, its subsidiary, and other related agencies from 2020 to 2023 to the Attorney General's Office.

BPK found irregularities indicating criminal acts committed by related parties in the financial management of Indofarma and its subsidiaries which resulted in indications of state losses of Rp371.83 billion.

This examination is a BPK initiative originating from the development of compliance checks on the Management of Revenue, Burden, and Investment Activities in 2020 to Semester I of 2023 at PT Indofarma Tbk, Subsidiaries, and Related Agencies.

Earlier this month, Minister of State-Owned Enterprises (BUMN) Erick Thohir also confirmed that his party was ready to bring Indofarma to the Attorney General's Office if irregularities were found. The Ministry of SOEs also coordinated with BPK regarding the financial problems experienced by Indofarma. Indofarma in the disclosure of information on the Indonesia Stock Exchange (IDX) on April 18 has also admitted that it has not paid employee salaries for the March 2024 period, because this red-plated pharmaceutical company is experiencing financial problems.